Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
ENA 2020
24 - 25 Oct 2020
Online, Online, United Kingdom
Big data, machine learning and drug discovery in oncology
Prof Bissan Al-Lazikani - Institute of Cancer Research, London, UK
18 Dec 2020
Targeting a KRAS neoantigen peptide vaccine to DNGR-1 dendritic cells
Dr Rachel Ambler - The Francis Crick Institute, London, United Kingdom
27 Nov 2020
Using circulating tumour DNA dynamics to predict outcomes in advanced cancers
Dr Mohamed Gouda - The University of Texas MD Anderson Cancer Center, Houston, U...
23 Nov 2020
Interim results from a phase 1/2 precision medicine study of PLX8394- a next gen...
Dr Filip Janku - The University of Texas MD Anderson Cancer Center USA
17 Nov 2020
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
4 Nov 2020
Prospective validation of single mouse testing by the paediatric preclinical tes...
Dr Peter Houghton - Greehey Children's Cancer Institute, San Antonio, USA
4 Nov 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
4 Nov 2020
The ENA virtual meeting 2020
Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
4 Nov 2020
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation
Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA
4 Nov 2020
Development of novel inhibitors of KRASG12C
Dr Kevan Shokat - University of California San Francisco, San Francisco, USA
4 Nov 2020
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 ba...
Dr Julius Strauss - National Institutes of Health, Bethseda, USA
4 Nov 2020
